Emerging evidence has shown that TRIM22 plays critical roles in tumorigenesis and cancer development, including chronic myeloid leukemia [21], nonsmall cell lung cancer [22], and gliomas [23]. The gene discussed is TRIM22; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.